Tech Company Financing Transactions
Agenus Funding Round
Agenus secured a investment round on 6/3/2025. Backers included Zynext Ventures.
Transaction Overview
Company Name
Announced On
6/3/2025
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to expand operations and R&D efforts to accelerate development of its lead BOT/BAL program and strategically expand into high-unmet need indications and earlier lines of treatment.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
3 Forbes Road
Lexington, MA 02421
USA
Lexington, MA 02421
USA
Phone
Website
Email Address
Not Recorded
Overview
Our mission is to harness the power of the immune system to bring therapies with curative intent to individuals living with cancer. Agenus discovers, manufactures, and develops immuno-oncology (I-O) therapeutics. Our vision is to expand the patient population benefiting from I-O through combination approaches that leverage a broad repertoire of antibody therapeutics, adoptive cell therapies (through subsidiary MiNK Therapeutics), adjuvants and vaccines (through subsidiary SaponiQx).
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 6/3/2025: Valla venture capital transaction
Next: 6/3/2025: Impulse Space venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document every notable VC transaction. VC transactions on this site come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs